[go: up one dir, main page]

NO20063114L - Enoxaparin for behandling av cancer - Google Patents

Enoxaparin for behandling av cancer

Info

Publication number
NO20063114L
NO20063114L NO20063114A NO20063114A NO20063114L NO 20063114 L NO20063114 L NO 20063114L NO 20063114 A NO20063114 A NO 20063114A NO 20063114 A NO20063114 A NO 20063114A NO 20063114 L NO20063114 L NO 20063114L
Authority
NO
Norway
Prior art keywords
enoxaparin
cancer
treatment
Prior art date
Application number
NO20063114A
Other languages
English (en)
Inventor
ANDRé UZAN
Umesh Shukla
Rita Samuel
Luis Toro-Figueroa
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20063114L publication Critical patent/NO20063114L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20063114A 2003-12-04 2006-07-04 Enoxaparin for behandling av cancer NO20063114L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03293028A EP1537871A1 (en) 2003-12-04 2003-12-04 Enoxaparin for the treatment of cancer
PCT/EP2004/014807 WO2005053713A1 (en) 2003-12-04 2004-12-01 Enoxaparin for the treatment of cancer

Publications (1)

Publication Number Publication Date
NO20063114L true NO20063114L (no) 2006-08-29

Family

ID=34443115

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063114A NO20063114L (no) 2003-12-04 2006-07-04 Enoxaparin for behandling av cancer

Country Status (12)

Country Link
US (1) US20050164985A1 (no)
EP (2) EP1537871A1 (no)
JP (1) JP2007513123A (no)
KR (1) KR20060109929A (no)
AU (1) AU2004294730A1 (no)
BR (1) BRPI0417371A (no)
CA (1) CA2546292A1 (no)
IL (1) IL175689A0 (no)
MX (1) MXPA06006275A (no)
NO (1) NO20063114L (no)
WO (1) WO2005053713A1 (no)
ZA (1) ZA200604409B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381410B2 (en) * 2003-03-12 2008-06-03 Vasgene Therapeutics, Inc. Polypeptide compounds for inhibiting angiogenesis and tumor growth
WO2010013231A2 (en) * 2008-07-29 2010-02-04 Yeda Research And Development Co. Ltd. Modulation of coagulation factors and effectors of same for control of transplant organ size
WO2010070118A1 (en) 2008-12-19 2010-06-24 Aktiebolaget Skf A machine part comprising a physical component coated with a polyelectrolyte layer
WO2014193821A1 (en) * 2013-05-28 2014-12-04 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions comprising pyrophosphate
EP3183342B1 (en) * 2014-08-20 2021-05-12 Health Research, Inc. Method for prophylaxis and/or treatment of erbb1 positive cancers
CN110548045A (zh) * 2018-05-30 2019-12-10 北京大学 低分子肝素-抗肿瘤药物静电复合物纳米系统的制备方法及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492332B1 (en) * 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
ATE469244T1 (de) * 1996-07-23 2010-06-15 Nagase Chemtex Corp Verfahren zur herstellung von docosahexansäure und docosapentansäure
AU754936B2 (en) * 1996-11-27 2002-11-28 Aventis Pharmaceuticals Inc. Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound
US6541036B1 (en) * 1997-05-29 2003-04-01 Thomas Jefferson University Treatment of tumors with oligonucleotides directed to insulin-like growth factor-I receptors (IGF-IR)
US6690976B2 (en) * 2000-04-13 2004-02-10 Celsion Corporation Thermotherapy method for treatment and prevention of breast cancer and cancer in other organs
DE10026699A1 (de) * 2000-05-30 2001-12-06 Basf Ag Formulierung auf Heparin-, Glycosaminoglycan- oder Heparinoidbasis und Verwendung der Formulierung sowie der Formulierungsgrundlage
DE10141106A1 (de) * 2001-08-22 2003-03-13 Aventis Pharma Gmbh Verwendung von Heparinoid-Derivaten zur Behandlung und Diagnose von mit Heparinoiden behandelbaren Erkrankungen
CA2478700C (en) * 2002-03-11 2012-10-16 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
US6908907B2 (en) * 2002-04-22 2005-06-21 El-Naggar Mawaheb M. Prevention and treatment of tumor growth, metastasis, and thromboembolic complications in cancer patients

Also Published As

Publication number Publication date
US20050164985A1 (en) 2005-07-28
KR20060109929A (ko) 2006-10-23
CA2546292A1 (en) 2005-06-16
EP1537871A1 (en) 2005-06-08
IL175689A0 (en) 2008-03-20
BRPI0417371A (pt) 2007-04-10
ZA200604409B (en) 2007-09-26
MXPA06006275A (es) 2006-08-23
WO2005053713A1 (en) 2005-06-16
EP1694340A1 (en) 2006-08-30
AU2004294730A1 (en) 2005-06-16
JP2007513123A (ja) 2007-05-24

Similar Documents

Publication Publication Date Title
IS8125A (is) Kínasólínafleiður til að meðhöndla krabbamein
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
IL169594A0 (en) Treatment of cancer with 2-deoxyglucose
NO20070251A (no) Brønnbehandling
SE531352C8 (sv) Spiroalkanderivat och användning av dessa föreningar för behandling av artrit, cancer, kardiovaskulära sjukdomar, hudsjukdomar och inflammatoriska och allergiska tillstånd
NO20070297A (no) Brønnbehandling
EP1599196A4 (en) COMBINATION THERAPIES FOR CANCER TREATMENT
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
DK1499730T3 (da) Immunokonjugater til behandling af tumorer
SE0502484L (sv) Behandling av neurodegenerativa tillstånd
DE602004010856D1 (de) Bohrlochbehandlungsflüssigkeiten
DK1678085T3 (da) Fluidbehandlingsindretning
EP1594433A4 (en) SENSITIZING A CANCER THERAPY
NO20063443L (no) Piperziner effektive for behandling av smerte
IL177455A0 (en) Pyrazoline derivatives useful for the treatment of cancer
EP1789064A4 (en) ENHANCED ANTICANCER TREATMENT
NO20063114L (no) Enoxaparin for behandling av cancer
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
DE60328516D1 (de) Thia-epothilon derivate zur krebsbehandlung
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
NO20055449D0 (no) Fremgangsmate for diagnostisering av behandling av kreft
GB0329416D0 (en) Treatment of cancer
NO20042850L (no) Kreftbehandling
NO20033160D0 (no) Anordning for behandling av gravann
GB0410379D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application